Cipla gains on receiving nod for Cipla Medpro's takeover

01 Jul 2013 Evaluate

Cipla is currently trading at Rs. 397.30, up by 5.85 points or 1.49% from its previous closing of Rs. 391.45 on the BSE.

The scrip opened at Rs. 392.50 and has touched a high and low of Rs. 397.00 and Rs. 389.70 respectively. So far 85,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 435.00 on 09-Jan-2013 and a 52 week low of Rs. 310.95 on 29-Jun-2012.

Last one week high and low of the scrip stood at Rs. 392.80 and Rs. 372.40 respectively. The current market cap of the company is Rs. 31.98 crore.

The promoters holding in the company stood at 36.80%, while Institutions and Non-Institutions held 34.08% and 28.32% respectively. 

Cipla, a drug-maker received an approval from the Takeover Regulation Panel for its proposal to takeover Medpro in South Africa. The operative date of the scheme is expected to be mid-July and from July 16, the shares of Medpro are expected to be delisted from JSE. The company has also received approval from shareholders of Cipla Medpro to Cipla’s $488 million offer to acquire 100 per cent stake in it.

The company focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.

Cipla Share Price

1507.25 -9.95 (-0.66%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×